Orchid Pharma Limited has informed the Exchange about General Updates
ORCHPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Orchid Pharma has informed the stock exchanges that, following an NCLT Chennai order dated August 5, 2025, the company has completed the required public notice publications for the proposed amalgamation of Dhanuka Laboratories (Amalgamating Company) into Orchid Pharma (Amalgamated Company). The notices were published in the Indian Express (English, all-India edition) and Dina Thanthi (Tamil Nadu edition). This is a routine procedural step under the SEBI Listing Regulations, continuing from the earlier intimation of July 10, 2025 when the Joint Second Motion Petition was filed with the NCLT. No swap ratio, valuation, or financial terms have been disclosed in this filing.
This is a procedural update in an ongoing amalgamation process and does not change the deal's economics. Shareholders should await further updates on the swap ratio, NCLT/NCLAT approvals, and the scheme's effective date for the real impact on shareholding and stock price.